Skip to Main Content

Advertisement

Issue Archive

Table of Contents

STIMULUS REPORTS

CLINICAL TRIALS AND OBSERVATIONS

HEALTH SERVICES AND OUTCOMES

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

SYSTEMATIC REVIEW

  • Cover Image

    Cover Image

    issue cover

    COVER FIGURE
    Gilteritinib induces morphologic differentiation responses in a subset of patients with clinical responses to it. The bone marrow aspirate shown here, collected from a patient with a differentiation response to gilteritinib, shows a reduction in marrow blast percentage with marked granulocytic hyperplasia with a left shift. In patients with differentiation responses, the FLT3 mutation allelic burden remains elevated throughout the period of clinical response. The aspirate smear shown here is a Wright-Giemsa stain at 500× objective magnification (oil immersion). See the article by McMahon et al.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkEditorial Board
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal

Advertisement

X